MediXall Group, Inc.

$ Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000155335022000902 Filed on November 14, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q3

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.420K	$75.58K	$349.5K
YoY Change	-94.61%	-78.38%	-32.71%
Cash & Equivalents	$3.416K	$75.58K	$349.5K
Short-Term Investments
Other Short-Term Assets	$8.083K	$20.52K	$309.2K
YoY Change	132.0%	-93.36%	3.88%
Inventory
Prepaid Expenses	$0.00	$0.00
Receivables
Other Receivables
Total Short-Term Assets	$11.50K	$96.10K	$658.7K
YoY Change	-96.65%	-85.41%	-19.38%
LONG-TERM ASSETS
Property, Plant & Equipment	$21.76K	$21.76K	$354.3K
YoY Change	-6.93%	-93.86%	298.26%
Goodwill
YoY Change
Intangibles	$412.6K	$432.0K
YoY Change	-8.6%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$850.5K	$924.6K	$807.4K
YoY Change	7.85%	14.52%	56.34%
TOTAL ASSETS
Total Short-Term Assets	$11.50K	$96.10K	$658.7K
Total Long-Term Assets	$850.5K	$924.6K	$807.4K
Total Assets	$862.0K	$1.021M	$1.466M
YoY Change	-23.82%	-30.38%	9.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.710M	$1.655M	$1.038M
YoY Change	47.95%	59.53%	181.65%
Accrued Expenses	$75.69K	$20.33K	$333.1K
YoY Change	9.28%	-93.9%	408.83%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.556M	$2.017M	$0.00
YoY Change
Total Short-Term Liabilities	$4.342M	$3.692M	$1.371M
YoY Change	254.35%	169.36%	215.92%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities	$189.5K	$244.8K
YoY Change	-23.1%
Total Long-Term Liabilities	$189.5K	$244.8K	$0.00
YoY Change	-23.1%		-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.342M	$3.692M	$1.371M
Total Long-Term Liabilities	$189.5K	$244.8K	$0.00
Total Liabilities	$4.531M	$3.937M	$1.371M
YoY Change	207.9%	187.22%	128.61%
SHAREHOLDERS EQUITY
Retained Earnings	-$32.61M	-$30.83M
YoY Change	26.49%
Common Stock	$122.2K	$116.9K
YoY Change	10.21%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$3.669M	-$2.916M	$95.36K
YoY Change
Total Liabilities & Shareholders Equity	$862.0K	$1.021M	$1.466M
YoY Change	-23.82%	-30.38%	9.94%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q3

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001601280
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
CY2021Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent		usd
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock		usd
	mdxl	Decrease In Note Payable Resulting From Gain On Forgiveness Of Note Payable DecreaseInNotePayableResultingFromGainOnForgivenessOfNotePayable		usd
	mdxl	Retirement Of Common Shares Issued For Services RetirementOfCommonSharesIssuedForServices		usd
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Type DocumentType	10-Q
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33308
	dei	City Area Code CityAreaCode	954
	dei	Local Phone Number LocalPhoneNumber	440-4678
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	333-194337
	dei	Entity Registrant Name EntityRegistrantName	MediXall Group, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	33-0864127
	dei	Entity Address Address Line1 EntityAddressAddressLine1	2929 East Commercial Blvd.
	dei	Entity Address Address Line2 EntityAddressAddressLine2	PH-D
	dei	Entity Address City Or Town EntityAddressCityOrTown	Ft. Lauderdale
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	117350039	shares
CY2022Q3	us-gaap	Cash Cash	75578	usd
CY2021Q4	us-gaap	Cash Cash	63418	usd
CY2022Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	0	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	276043	usd
CY2022Q3	us-gaap	Other Assets Current OtherAssetsCurrent	20524	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	3484	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	96102	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	342945	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	21755	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	23376	usd
CY2022Q3	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	210713	usd
CY2021Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	0	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	260177	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	313856	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	431993	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	451404	usd
CY2022Q3	us-gaap	Assets Assets	1020740	usd
CY2021Q4	us-gaap	Assets Assets	1131581	usd
CY2022Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	846508	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	588870	usd
CY2022Q3	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	808810	usd
CY2021Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	567202	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	20326	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	69258	usd
CY2022Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	197914	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	197914	usd
CY2022Q3	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	2016547	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	3692191	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1225330	usd
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	116873039	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	116873039	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	110864595	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	110864595	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	116873	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	244822	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	246373	usd
CY2022Q3	us-gaap	Liabilities Liabilities	3937013	usd
CY2021Q4	us-gaap	Liabilities Liabilities	1471703	usd
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000	shares
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	110864	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	27793044	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	25327230	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-30830364	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-25782390	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-2916273	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-340122	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1020740	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1131581	usd
CY2022Q3	us-gaap	Revenues Revenues	20766	usd
CY2021Q3	us-gaap	Revenues Revenues	3773	usd
	us-gaap	Revenues Revenues	39025	usd
	us-gaap	Revenues Revenues	173686	usd
CY2022Q3	us-gaap	Professional Fees ProfessionalFees	227914	usd
CY2021Q3	us-gaap	Professional Fees ProfessionalFees	323316	usd
	us-gaap	Professional Fees ProfessionalFees	824527	usd
	us-gaap	Professional Fees ProfessionalFees	1004976	usd
CY2022Q3	mdxl	Professional Fees Related Party ProfessionalFeesRelatedParty	50100	usd
CY2021Q3	mdxl	Professional Fees Related Party ProfessionalFeesRelatedParty	40000	usd
	mdxl	Professional Fees Related Party ProfessionalFeesRelatedParty	227600	usd
	mdxl	Professional Fees Related Party ProfessionalFeesRelatedParty	451038	usd
CY2022Q3	mdxl	Management Fee Related Party ManagementFeeRelatedParty	240000	usd
CY2021Q3	mdxl	Management Fee Related Party ManagementFeeRelatedParty	240000	usd
	mdxl	Management Fee Related Party ManagementFeeRelatedParty	720000	usd
	mdxl	Management Fee Related Party ManagementFeeRelatedParty	600000	usd
CY2022Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	273120	usd
CY2021Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	533130	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	2587035	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1817042	usd
CY2022Q3	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	313510	usd
CY2021Q3	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	258498	usd
	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	727837	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4382688	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	327500	usd
	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	683318	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	1104644	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	1394944	usd
	us-gaap	Operating Expenses OperatingExpenses	5086999	usd
	us-gaap	Operating Expenses OperatingExpenses	4556374	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1083878	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1391171	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5047974	usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-1083878	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-1391171	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5047974	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4382688	usd
CY2022Q3	us-gaap	Dividends Preferred Stock DividendsPreferredStock	78995	usd
CY2021Q3	us-gaap	Dividends Preferred Stock DividendsPreferredStock	65636	usd
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	234410	usd
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	214414	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1162873	usd
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1456807	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5282384	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4597102	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	116886659	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	105948985	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	115896191	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	103147965	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	116886659	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	105948985	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	115896191	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	103147965	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	381904	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	621875	usd
CY2021Q1	mdxl	Proceeds Received From Sale Of Preferred Stock ProceedsReceivedFromSaleOfPreferredStock	1345000	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-1332301	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	1016478	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	95357	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	678375	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-1659216	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	363137	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	413416	usd
CY2021Q3	mdxl	Proceeds Received From Sale Of Preferred Stock ProceedsReceivedFromSaleOfPreferredStock	699975	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	10000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-1391171	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-340122	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	720000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	1094929	usd
CY2022Q1	mdxl	Common Stock Issued In Exchange For Righttouse Intellectual Property CommonStockIssuedInExchangeForRighttouseIntellectualProperty	236000	usd
CY2022Q1	mdxl	Fair Value Of Warrants Issued With Convertible Debentures FairValueOfWarrantsIssuedWithConvertibleDebentures	23800	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2410102	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-675495	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	40500	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	365398	usd
CY2022Q2	mdxl	Fair Value Of Warrants Issued With Convertible Debentures FairValueOfWarrantsIssuedWithConvertibleDebentures	59146	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-1553994	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-1764445	usd
CY2022Q3	mdxl	Fair Value Of Warrants Issued With Convertible Debentures FairValueOfWarrantsIssuedWithConvertibleDebentures	174750	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	72800	usd
CY2022Q3	mdxl	Retirement Of Common Shares Issued For Services Unaudited RetirementOfCommonSharesIssuedForServicesUnaudited	-315500	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-1083878	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-2916273	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5047974	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4382688	usd
	us-gaap	Depreciation Depreciation	1621	usd
	us-gaap	Depreciation Depreciation	3840	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	1217627	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	688375	usd
	mdxl	Amortization Of Debenture Discounts AmortizationOfDebentureDiscounts	-59781	usd
	mdxl	Amortization Of Debenture Discounts AmortizationOfDebentureDiscounts	-0	usd
	mdxl	Gain From Forgiveness Of Note Payable GainFromForgivenessOfNotePayable	-0	usd
	mdxl	Gain From Forgiveness Of Note Payable GainFromForgivenessOfNotePayable	165719	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	17040	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-4516	usd
	mdxl	Increase Decrease In Prepaid Expenses Related Party IncreaseDecreaseInPrepaidExpensesRelatedParty	276043	usd
	mdxl	Increase Decrease In Prepaid Expenses Related Party IncreaseDecreaseInPrepaidExpensesRelatedParty	174304	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	257638	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-94335	usd
	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	241608	usd
	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	83350	usd
	mdxl	Amortization Of Rightofuse Operating Lease Asset AmortizationOfRightofuseOperatingLeaseAsset	53679	usd
	mdxl	Amortization Of Rightofuse Operating Lease Asset AmortizationOfRightofuseOperatingLeaseAsset	36754	usd
	mdxl	Amortization Of Righttouse Intellectual Property AmortizationOfRighttouseIntellectualProperty	25287	usd
	mdxl	Amortization Of Righttouse Intellectual Property AmortizationOfRighttouseIntellectualProperty	0	usd
	mdxl	Increase Decrease Amortization Of Website And Development IncreaseDecreaseAmortizationOfWebsiteAndDevelopment	19411	usd
	mdxl	Increase Decrease Amortization Of Website And Development IncreaseDecreaseAmortizationOfWebsiteAndDevelopment	0	usd
	us-gaap	Increase Decrease In Operating Liabilities IncreaseDecreaseInOperatingLiabilities	-50483	usd
	us-gaap	Increase Decrease In Operating Liabilities IncreaseDecreaseInOperatingLiabilities	-38707	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2962802	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3690310	usd
	mdxl	Website And Development Costs WebsiteAndDevelopmentCosts	-0	usd
	mdxl	Website And Development Costs WebsiteAndDevelopmentCosts	13680	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-13680	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	760500	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1362791	usd
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	2044975	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	2214462	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2974962	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3407766	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	12160	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-296224	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	63418	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	645762	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	75578	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	349538	usd
	mdxl	Issuance Of Common Stock In Exchange For Righttouse Intellectual Property IssuanceOfCommonStockInExchangeForRighttouseIntellectualProperty	236000	usd
	mdxl	Issuance Of Common Stock In Exchange For Righttouse Intellectual Property IssuanceOfCommonStockInExchangeForRighttouseIntellectualProperty	0	usd
	mdxl	Discount Issued With Convertible Debentures DiscountIssuedWithConvertibleDebentures	257695	usd
	mdxl	Discount Issued With Convertible Debentures DiscountIssuedWithConvertibleDebentures	0	usd
	mdxl	Decrease In Note Payable Resulting From Gain On Forgiveness Of Note Payable DecreaseInNotePayableResultingFromGainOnForgivenessOfNotePayable	-165719	usd
	mdxl	Rightofuse Lease Assets Obtained In Exchange For Operating Lease Liabilities RightofuseLeaseAssetsObtainedInExchangeForOperatingLeaseLiabilities	0	usd
	mdxl	Rightofuse Lease Assets Obtained In Exchange For Operating Lease Liabilities RightofuseLeaseAssetsObtainedInExchangeForOperatingLeaseLiabilities	324589	usd
	mdxl	Retirement Of Common Shares Issued For Services RetirementOfCommonSharesIssuedForServices	315500	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_849_eus-gaap--ConcentrationRiskCreditRisk_zqnW5eXpZH97" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span id="xdx_86F_zD9uNqNPh0aj">Risks and Uncertainties</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">The Company's operations are subject to significant risks and uncertainties including financial, operational and regulatory risks, including the potential risk of business failure. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
CY2022Q1	mdxl	Intellectual Property Value IntellectualPropertyValue	236000	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-30830364	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_845_eus-gaap--UseOfEstimates_zZ4CHkpuc6vc" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span id="xdx_869_zVtGXNR5UQ34">Use of Estimates</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">The preparation of the unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed consolidated financial statements, which management considered in formulating its estimate could change in the near term due to one or more future non-conforming events. Accordingly, the actual results could differ significantly from estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">A material estimate that is particularly susceptible to significant change in the near-term relate to the determination of the impairment of website and development cost. The Company uses various assumptions it believes to be reasonable under the circumstances to make this estimate. Although considerable variability is likely to be inherent in this estimate, management believes that the amount provided is reasonable. This estimate is continually reviewed and adjusted if necessary. Such adjustments are reflected in current operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-1083878	usd
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-1391171	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-5047974	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-4382688	usd
CY2022Q3	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	78995	usd
CY2021Q3	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	65636	usd
	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	234410	usd
	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	214414	usd
CY2022Q3	mdxl	Loss Available To Common Stockholders LossAvailableToCommonStockholders	-1162873	usd
CY2021Q3	mdxl	Loss Available To Common Stockholders LossAvailableToCommonStockholders	-1456807	usd
	mdxl	Loss Available To Common Stockholders LossAvailableToCommonStockholders	-5282384	usd
	mdxl	Loss Available To Common Stockholders LossAvailableToCommonStockholders	-4597102	usd
CY2022Q3	mdxl	Weighted Average Number Of Common Shares Outstanding WeightedAverageNumberOfCommonSharesOutstanding	116886659	shares
CY2021Q3	mdxl	Weighted Average Number Of Common Shares Outstanding WeightedAverageNumberOfCommonSharesOutstanding	105948985	shares
	mdxl	Weighted Average Number Of Common Shares Outstanding WeightedAverageNumberOfCommonSharesOutstanding	115896191	shares
	mdxl	Weighted Average Number Of Common Shares Outstanding WeightedAverageNumberOfCommonSharesOutstanding	103147965	shares
CY2022Q3	mdxl	Basic And Diluted Lps BasicAndDilutedLps	-0.01	shares
CY2021Q3	mdxl	Basic And Diluted Lps BasicAndDilutedLps	-0.01	shares
	mdxl	Basic And Diluted Lps BasicAndDilutedLps	-0.05	shares
	mdxl	Basic And Diluted Lps BasicAndDilutedLps	-0.04	shares
CY2022Q3	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2021Q3	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	236000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-25287	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	210713	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths	8429	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Two FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo	33714	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Three FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree	33714	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Four FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour	33714	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Five FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive	33714	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive	67428	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	210713	usd
CY2021Q2	us-gaap	Debt Instrument Periodic Payment DebtInstrumentPeriodicPayment	40000	usd
CY2022Q3	us-gaap	Related Party Transaction Due From To Related Party RelatedPartyTransactionDueFromToRelatedParty	-808810	usd
CY2021Q4	us-gaap	Related Party Transaction Due From To Related Party RelatedPartyTransactionDueFromToRelatedParty	-291159	usd
CY2022Q1	mdxl	Securities Purchase Agreement Description SecuritiesPurchaseAgreementDescription	In March 2022, the Company entered into a securities purchase agreement in which the Company maximum offering amount is $5,000,000. For every $1,000 invested in the offering, the Investors will receive a Debenture with a face amount of $1,000 and Warrants to purchase 350 Common Shares at an exercise price that ranges from $0.75 to $1.50 per share expiring on April 30, 2027.
CY2022Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	775425	shares
CY2022Q3	us-gaap	Share Price SharePrice	0.40
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2022Q3	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	257695	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	59781	usd

Files In Submission

Name	View Source	Status
0001553350-22-000902-index-headers.html	Edgar Link	pending
0001553350-22-000902-index.html	Edgar Link	pending
0001553350-22-000902.txt	Edgar Link	pending
0001553350-22-000902-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
mdxl-20220930.xsd	Edgar Link	pending
mdxl_10q.htm	Edgar Link	pending
mdxl_ex31z1.htm	Edgar Link	pending
mdxl_ex31z2.htm	Edgar Link	pending
mdxl_ex32z1.htm	Edgar Link	pending
mdxl_ex32z2.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
mdxl-20220930_cal.xml	Edgar Link	unprocessable
mdxl-20220930_def.xml	Edgar Link	unprocessable
mdxl-20220930_lab.xml	Edgar Link	unprocessable
mdxl-20220930_pre.xml	Edgar Link	unprocessable
mdxl_10q_htm.xml	Edgar Link	completed
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

MediXall Group, Inc.

2022 Q4 Form 10-Q Financial Statement

#000155335022000902 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission